We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
908 Devices
MASS
$473M
| $320K | ﹤0.01% |
36,791
+2,241
| +6% | +$17.2K |
|
2802
Verastem
VSTM
$701M
| $320K | ﹤0.01% |
83,678
+11,705
| +16% | +$56.6K |
|
|
EIKN
2803
Eikon Therapeutics
EIKN
$429M
| $319K | ﹤0.01% |
+24,483
| New | +$250K |
|
2804
National CineMedia
NCMI
$213M
| $319K | ﹤0.01% |
83,869
-73
| -0.1% | -$249 |
|
2805
Assembly Biosciences
ASMB
$482M
| $318K | ﹤0.01% |
11,590
+11,400
| +6,000% | +$310K |
|
2806
Distribution Solutions Group
DSGR
$1.62B
| $318K | ﹤0.01% |
11,620
+95
| +0.8% | +$2.6K |
|
2807
Nuvectis Pharma
NVCT
$660M
| $318K | ﹤0.01% |
17,271
+8,614
| +100% | +$96.4K |
|
2808
Zumiez
ZUMZ
$204M
| $317K | ﹤0.01% |
17,784
-162
| -0.9% | -$3.62K |
|
2809
NRC Health Common Stock
NRC
$433M
| $315K | ﹤0.01% |
14,619
-818
| -5% | -$15.2K |
|
2810
Fidelity D&D Bancorp
FDBC
$324M
| $315K | ﹤0.01% |
6,119
+108
| +2% | +$5.04K |
|
2811
Century Therapeutics
IPSC
$302M
| $315K | ﹤0.01% |
+128,404
| New | +$293K |
|
|
VOXR
2812
Vox Royalty Corp
VOXR
$378M
| $314K | ﹤0.01% |
66,443
+12,179
| +22% | +$67K |
|
2813
MacroGenics
MGNX
$238M
| $314K | ﹤0.01% |
+67,920
| New | +$257K |
|
|
AVBH
2814
Avidbank Holdings
AVBH
$345M
| $314K | ﹤0.01% |
9,498
+7,044
| +287% | +$215K |
|
2815
Rentokil
RTO
$10.4B
| $312K | ﹤0.01% |
10,901
+1,761
| +19% | +$55.9K |
|
2816
OppFi
OPFI
$535M
| $311K | ﹤0.01% |
31,343
+841
| +3% | +$7.28K |
|
2817
LCNB Corp
LCNB
$268M
| $311K | ﹤0.01% |
17,654
+624
| +4% | +$10.4K |
|
2818
Full Truck Alliance
YMM
$8.44B
| $311K | ﹤0.01% |
38,240
+35,682
| +1,395% | +$304K |
|
2819
Usana Health Sciences
USNA
$268M
| $310K | ﹤0.01% |
14,510
-984
| -6% | -$18.5K |
|
2820
Oak Valley Bancorp
OVLY
$287M
| $307K | ﹤0.01% |
9,105
+484
| +6% | +$16.3K |
|
2821
BK Technologies
BKTI
$282M
| $307K | ﹤0.01% |
3,569
+151
| +4% | +$13.1K |
|
|
INV
2822
Innventure Inc
INV
$61.5M
| $306K | ﹤0.01% |
60,443
+30,993
| +105% | +$182K |
|
2823
Virgin Galactic
SPCE
$484M
| $306K | ﹤0.01% |
+105,783
| New | +$346K |
|
2824
Petco
WOOF
$650M
| $305K | ﹤0.01% |
112,318
+11,077
| +11% | +$30.7K |
|
|
ACRE
2825
Ares Commercial Real Estate
ACRE
$232M
| $305K | ﹤0.01% |
67,754
+109
| +0.2% | +$538 |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.